Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4713)
All Articles published online
|
Publishing Process of This Article
|
Aug 28, 2013 (publication date) through Apr 17, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Radiology
ISSN
1949-8470
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Plataniotis GA, Dale RG. Radio-chemotherapy for bladder cancer: Contribution of chemotherapy on local control. World J Radiol 2013; 5(8): 267-274 [PMID: 24003352 DOI: 10.4329/wjr.v5.i8.267] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8470/full/v5/i8/267.htm |
| Number | Citing Articles |
| 1 |
Artur Lemiński, Wojciech Michalski, Bartłomiej Masojć, Krystian Kaczmarek, Bartosz Małkiewicz, Jakub Kienitz, Barbara Zawisza-Lemińska, Michał Falco, Marcin Słojewski. Combined Modality Bladder-Sparing Therapy for Muscle-Invasive Bladder Cancer: How (Should) We Do It? A Narrative Review. Journal of Clinical Medicine 2023; 12(4): 1560 doi: 10.3390/jcm12041560
|
| 2 |
Chao Xu, Wen Zou, Yinhuai Wang, Xianling Liu, Jingjing Wang. Bladder-sparing treatment for muscle-invasive bladder carcinoma using immune checkpoint inhibitors. Critical Reviews in Oncology/Hematology 2023; 191: 104137 doi: 10.1016/j.critrevonc.2023.104137
|
| 3 |
Michael Cardoso, Ananya Choudhury, David Christie, Thomas Eade, Farshad Foroudi, Amy Hayden, Tanya Holt, Andrew Kneebone, Giuseppe Sasso, Thomas P. Shakespeare, Mark Sidhom. FROGG patterns of practice survey and consensus recommendations on radiation therapy for MIBC. Journal of Medical Imaging and Radiation Oncology 2020; 64(6): 882 doi: 10.1111/1754-9485.13120
|
| 4 |
Michaela Medová, Daniel Aebersold, Yitzhak Zimmer. The Molecular Crosstalk between the MET Receptor Tyrosine Kinase and the DNA Damage Response—Biological and Clinical Aspects. Cancers 2013; 6(1): 1 doi: 10.3390/cancers6010001
|
| 5 |
Claudio Albertoni, Barbara Leoni, Antonio Rosi, Valeria D'Alessio, Valeria Carollo, Luigi Giusto Spagnoli, Cees van Echteld, Rita De Santis. Radionuclide Therapy of Unresectable Tumors with AvidinOX and 90Y-biotinDOTA: Tongue Cancer Paradigm. Cancer Biotherapy and Radiopharmaceuticals 2015; 30(7): 291 doi: 10.1089/cbr.2015.1837
|
| 6 |
Henk van der Poel. Re: Transurethral Surgery and Twice-daily Radiation Plus Paclitaxel-Cisplatin or Fluorouracil-Cisplatin with Selective Bladder Preservation and Adjuvant Chemotherapy for Patients with Muscle Invasive Bladder Cancer (RTOG 0233): A Randomised Multicentre Phase 2 Trial. European Urology 2014; 65(6): 1221 doi: 10.1016/j.eururo.2014.02.028
|
| 7 |
Catherine Thompson, Nuradh Joseph, Benjamin Sanderson, John Logue, James Wylie, Tony Elliott, Jeanette Lyons, Carmel Anandadas, Ananya Choudhury. Tolerability of Concurrent Chemoradiation Therapy With Gemcitabine (GemX), With and Without Prior Neoadjuvant Chemotherapy, in Muscle Invasive Bladder Cancer. International Journal of Radiation Oncology*Biology*Physics 2017; 97(4): 732 doi: 10.1016/j.ijrobp.2016.11.040
|
| 8 |
Mark Korpics, Alec M. Block, Basel Altoos, Brendan Martin, Kyle Carey, James Welsh, Matthew M. Harkenrider, Abhishek A. Solanki. Maximizing survival in patients with muscle-invasive bladder cancer undergoing curative bladder-preserving radiotherapy: the impact of radiotherapy dose escalation. Journal of Radiation Oncology 2017; 6(4): 387 doi: 10.1007/s13566-017-0319-2
|
| 9 |
A.A. Baulin, L.G. Sukhikh, E.S. Sukhikh. Simulation of dose enhancement in radiotherapy caused by cisplatin. Journal of Instrumentation 2020; 15(06): C06061 doi: 10.1088/1748-0221/15/06/C06061
|